REGNNEUTRAL

Gross Margin

81.4%

Higher than 77% of Healthcare sector peers

Updated 267h ago

Sector Performance

77th percentile

REGN

81.4%

Sector Median

69.8%

Sector Avg

-24.1%

📊

Deep Analysis

Gross margin measures the percentage of revenue a company keeps after paying the direct costs of producing its goods, so an 81.4% figure means Regeneron retains over 81 cents of every dollar in sales.

This is above the healthcare sector median of 69.4%, placing the company in the 78th percentile of its peers—indicating a strong cost advantage relative to competitors. The year-over-year and quarter-over-quarter changes are listed as N/A, and with only one historical data point available, no trend can be assessed. A high gross margin level suggests pricing power or efficient production, but the absence of trend data leaves uncertainty about whether this strength is stable or deteriorating. This metric supports the overall NEUTRAL verdict by showing a competitive edge that is not contradicted by available information, yet it does not alone justify a bullish or bearish stance due to the lack of directional evidence.

Frequently Asked Questions

What does the Gross Margin tell investors about REGN?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does REGN's Gross Margin compare to its sector?

REGN's Gross Margin of 81.4% compares to a Healthcare sector median of 69.8%, placing it in the 77th percentile.

Who are REGN's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: BMY (70.2%), TDOC (67.8%), TECH (66.9%), RMD (62.2%), BAYRY (61.0%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.